Walleye Trading LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2023$566,258
-21.6%
6,843
-38.3%
0.00%
-50.0%
Q2 2022$722,000
+6.2%
11,084
-13.5%
0.00%0.0%
Q4 2021$680,000
-65.8%
12,816
-54.5%
0.00%
-71.4%
Q3 2021$1,989,000
-0.2%
28,183
-5.7%
0.01%
-12.5%
Q2 2021$1,992,000
+7014.3%
29,902
+4171.7%
0.01%
Q4 2016$28,000
+100.0%
700
+75.0%
0.00%
Q3 2016$14,000
+16.7%
400
+33.3%
0.00%
Q2 2015$12,0003000.00%
Other shareholders
HAEMONETICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders